ANGLE ORD 10P news, videos and press releases
For more news please use our advanced search feature.
ANGLE ORD 10P - More news...
ANGLE ORD 10P - More news...
- Angle PLC Announces Issue of LTIP Options and Share Options
- Angle PLC Announces Results of Eisai Phase 2 pilot study
- Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay
- Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich
- Angle PLC Announces HER2 Presentation at SABCS
- Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
- Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
- ANGLE presents two posters at EACR
- Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
- Angle PLC Announces Publication Demonstrates CTC Profiling Potential
- Angle PLC Announces 100th Publication Supporting Parsortix System Use
- Angle PLC Announces Half-year Report
- Angle PLC Announces Exclusive agreement for DNA NGS panel
- Angle PLC Announces Agreement with Recursion Pharmaceuticals
- Angle PLC Announces Notice of Interim Results and Webcast
- Angle PLC Announces Standard Form for Notification of Major Holdings
- Angle PLC Announces Standard Form for Notification of Major Holdings
- Angle PLC Announces Result of 2024 Annual General Meeting
- Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
- Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
- Angle PLC Announces Preliminary Results
- Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
- Angle PLC Announces Potential Utility in Precision Oncology
- Angle PLC Announces Parsortix Unlocks Opportunities for Drug Discovery
- Angle PLC Announces Broker Announcement
- Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies
- Angle PLC Announces Supporting characterisation of CTCs in HNSCC
- Angle PLC Announces Interim Results for the Period Ended 30 June 2023
- Angle PLC Announces Result of 2023 Annual General Meeting
- ANGLE Announces Senior Management Appointments
